Testing effectiveness (Phase 2)UnknownNCT05739045What this trial is testingNivolumab Combined With SOX Used in the Perioperative TreatmentWho this might be right forImmune SuppressionGastric Cancer Xiangdong Cheng 46
Testing effectiveness (Phase 2)Study completedNCT00527930What this trial is testingPhase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast CancerWho this might be right forBreast Neoplasms Seoul National University Hospital 87
Testing effectiveness (Phase 2)Looking for participantsNCT07483567What this trial is testingIBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of Resectable, Locally Advanced Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forCLDN18.2 PositivePrimary Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma Innovent Biologics (Suzhou) Co. Ltd. 90
Testing effectiveness (Phase 2)UnknownNCT03279614What this trial is testingStudy to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine CarcinomaWho this might be right forNeuroendocrine Carcinoma Peking University 45
Early research (Phase 1)UnknownNCT05396326What this trial is testingA Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric CancerWho this might be right forGastric Cancer Shanghai Zhongshan Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07315035What this trial is testingQL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric CancerWho this might be right forGastric Cancer Stage III The First Affiliated Hospital with Nanjing Medical University 74
Testing effectiveness (Phase 2)UnknownNCT05024812What this trial is testingFruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forMetastatic Gastric Cancer The First Affiliated Hospital of Zhengzhou University 64
Testing effectiveness (Phase 2)Looking for participantsNCT04908566What this trial is testingImmune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forLocally Advanced Gastric Adenocarcinoma Tianjin Medical University Cancer Institute and Hospital 124
Not applicableNot Yet RecruitingNCT07674342What this trial is testingNeoadjuvant PD-1 Inhibitor Plus SOX Chemotherapy With or Without Short-Course Radiotherapy for Locally Advanced Upper Gastric or GEJ AdenocarcinomaWho this might be right forLocally Advanced Proximal Gastric or Gastroesophageal Junction Adenocarcinoma Tongji Hospital 146
Testing effectiveness (Phase 2)Looking for participantsNCT06461910What this trial is testingEfficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric CancerEsophagogastric Junction Adenocarcinoma Zekuan Xu 30
Testing effectiveness (Phase 2)UnknownNCT01542294What this trial is testingSOX as Adjuvant Chemotherapy for Resectable Gastric CancerWho this might be right forGastric Cancer Chinese Academy of Medical Sciences 71
Large-scale testing (Phase 3)Active Not RecruitingNCT03691454What this trial is testingCompare Neoadjuvant DOS Combined With Toripalimab Versus SOX Combined With Toripalimab in Locally Advanced Gastric AdenocarcinomaWho this might be right forGastric Adenocarcinoma Peking University 248
Large-scale testing (Phase 3)Looking for participantsNCT05593458What this trial is testingTransarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1Who this might be right forLocally Advanced Gastric Carcinoma Zhejiang University 190
Large-scale testing (Phase 3)UnknownNCT02817425What this trial is testingA Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric CancerWho this might be right forGastric Cancer LanZhou University 300
Not applicableWithdrawnNCT01615692What this trial is testingThe 36-month Extension to Follow up Sub StudyWho this might be right forPostphlebitic SyndromePost-Thrombotic SyndromeDeep Vein Thrombosis Sir Mortimer B. Davis - Jewish General Hospital
Not applicableStudy completedNCT01615705What this trial is testingBiomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) TrialWho this might be right forDeep Venous Thrombosis Sir Mortimer B. Davis - Jewish General Hospital 803
Testing effectiveness (Phase 2)Active Not RecruitingNCT05177068What this trial is testingConversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric CancerWho this might be right forGastric Cancer Henan Cancer Hospital 42
Not applicableLooking for participantsNCT06277024What this trial is testingA Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma PatientsWho this might be right forOverall Response Rate Fujian Medical University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06685887What this trial is testingA Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal MetastasisWho this might be right forGastric Cancer Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 34
Testing effectiveness (Phase 2)Looking for participantsNCT07492615What this trial is testingA Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric Cancer or Gastroesophageal Junction Adenocarcinoma Fudan University 276